Global Preventable Vaccines Market Status, Trends and COVID-19 Impact Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
In the past few years, the Preventable Vaccines market experienced a huge change under the influence of COVID-19, the global market size of Preventable Vaccines reached (2021 Market size XXXX) million $ in 2021 from (2016 Market size XXXX) in 2016 with a CAGR of xx from 2016-2021 is. As of now, the global COVID-19 Coronavirus Cases have exceeded 200 million, and the global epidemic has been basically under control, therefore, the World Bank has estimated the global economic growth in 2021 and 2022. The World Bank predicts that the global economic output is expected to expand 4 percent in 2021 while 3.8 percent in 2022. According to our research on Preventable Vaccines market and global economic environment, we forecast that the global market size of Preventable Vaccines will reach (2026 Market size XXXX) million $ in 2026 with a CAGR of % from 2021-2026.
Due to the COVID-19 pandemic, according to World Bank statistics, global GDP has shrunk by about 3.5% in 2020. Entering 2021, Economic activity in many countries has started to recover and partially adapted to pandemic restrictions. The research and development of vaccines has made breakthrough progress, and many governments have also issued various policies to stimulate economic recovery, particularly in the United States, is likely to provide a strong boost to economic activity but prospects for sustainable growth vary widely between countries and sectors. Although the global economy is recovering from the great depression caused by COVID-19, it will remain below pre-pandemic trends for a prolonged period. The pandemic has exacerbated the risks associated with the decade-long wave of global debt accumulation. It is also likely to steepen the long-expected slowdown in potential growth over the next decade.
The world has entered the COVID-19 epidemic recovery period. In this complex economic environment, we published the Global Preventable Vaccines Market Status, Trends and COVID-19 Impact Report 2021, which provides a comprehensive analysis of the global Preventable Vaccines market , This Report covers the manufacturer data, including: sales volume, price, revenue, gross margin, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows the regional development status, including market size, volume and value, as well as price data. Besides, the report also covers segment data, including: type wise, industry wise, channel wise etc. all the data period is from 2015-2021E, this report also provide forecast data from 2021-2026.
Section 1: 100 USD——Market Overview
Section (2 3): 1200 USD——Manufacturer Detail
GlaxoSmithKline
Merck
Novartis
Pfizer
Sanofi
Takeda Pharmaceutical
Abbott
Roche
AstraZeneca
Mitsubishi Tanabe Pharma
Lupin
Serum Institute of India
LG Life Sciences
S K Chemicals
Shenzhen Kangtai Biological Products
Sinovac Biotech
Janssen Pharmaceuticals
Crucell
Bavarian Nordic
Baxter
Bharat Biotech
Dynavax
Bausch Health
Protein Sciences
Panacea Biotec
Section 4: 900 USD——Region Segmentation
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Italy)
Middle East and Africa (Middle East, Africa)
Section (5 6 7): 700 USD——
Product Type Segmentation
Adult Preventable Vaccines
Pediatric Preventable Vaccines
Application Segmentation
Bacterial Diseases
Virus Diseases
Channel (Direct Sales, Distribution Channel) Segmentation
Section 8: 500 USD——Market Forecast (2021-2026)
Section 9: 600 USD——Downstream Customers
Section 10: 200 USD——Raw Material and Manufacturing Cost
Section 11: 500 USD——Conclusion
Section 12: Research Method and Data Source
Section 1 Preventable Vaccines Market Overview
1.1 Preventable Vaccines Market Scope
1.2 COVID-19 Impact on Preventable Vaccines Market
1.3 Global Preventable Vaccines Market Status and Forecast Overview
1.3.1 Global Preventable Vaccines Market Status 2016-2021
1.3.2 Global Preventable Vaccines Market Forecast 2021-2026
Section 2 Global Preventable Vaccines Market Manufacturer Share
2.1 Global Manufacturer Preventable Vaccines Sales Volume
2.2 Global Manufacturer Preventable Vaccines Business Revenue
Section 3 Manufacturer Preventable Vaccines Business Introduction
3.1 GlaxoSmithKline Preventable Vaccines Business Introduction
3.1.1 GlaxoSmithKline Preventable Vaccines Sales Volume, Price, Revenue and Gross margin 2016-2021
3.1.2 GlaxoSmithKline Preventable Vaccines Business Distribution by Region
3.1.3 GlaxoSmithKline Interview Record
3.1.4 GlaxoSmithKline Preventable Vaccines Business Profile
3.1.5 GlaxoSmithKline Preventable Vaccines Product Specification
3.2 Merck Preventable Vaccines Business Introduction
3.2.1 Merck Preventable Vaccines Sales Volume, Price, Revenue and Gross margin 2016-2021
3.2.2 Merck Preventable Vaccines Business Distribution by Region
3.2.3 Interview Record
3.2.4 Merck Preventable Vaccines Business Overview
3.2.5 Merck Preventable Vaccines Product Specification
3.3 Manufacturer three Preventable Vaccines Business Introduction
3.3.1 Manufacturer three Preventable Vaccines Sales Volume, Price, Revenue and Gross margin 2016-2021
3.3.2 Manufacturer three Preventable Vaccines Business Distribution by Region
3.3.3 Interview Record
3.3.4 Manufacturer three Preventable Vaccines Business Overview
3.3.5 Manufacturer three Preventable Vaccines Product Specification
…
Section 4 Global Preventable Vaccines Market Segmentation (By Region)
4.1 North America Country
4.1.1 United States Preventable Vaccines Market Size and Price Analysis 2016-2021
4.1.2 Canada Preventable Vaccines Market Size and Price Analysis 2016-2021
4.1.3 Mexico Preventable Vaccines Market Size and Price Analysis 2016-2021
4.2 South America Country
4.2.1 Brazil Preventable Vaccines Market Size and Price Analysis 2016-2021
4.2.2 Argentina Preventable Vaccines Market Size and Price Analysis 2016-2021
4.3 Asia Pacific
4.3.1 China Preventable Vaccines Market Size and Price Analysis 2016-2021
4.3.2 Japan Preventable Vaccines Market Size and Price Analysis 2016-2021
4.3.3 India Preventable Vaccines Market Size and Price Analysis 2016-2021
4.3.4 Korea Preventable Vaccines Market Size and Price Analysis 2016-2021
4.3.5 Southeast Asia Preventable Vaccines Market Size and Price Analysis 2016-2021
4.4 Europe Country
4.4.1 Germany Preventable Vaccines Market Size and Price Analysis 2016-2021
4.4.2 UK Preventable Vaccines Market Size and Price Analysis 2016-2021
4.4.3 France Preventable Vaccines Market Size and Price Analysis 2016-2021
4.4.4 Spain Preventable Vaccines Market Size and Price Analysis 2016-2021
4.4.5 Italy Preventable Vaccines Market Size and Price Analysis 2016-2021
4.5 Middle East and Africa
4.5.1 Africa Preventable Vaccines Market Size and Price Analysis 2016-2021
4.5.2 Middle East Preventable Vaccines Market Size and Price Analysis 2016-2021
4.6 Global Preventable Vaccines Market Segmentation (By Region) Analysis 2016-2021
4.7 Global Preventable Vaccines Market Segmentation (By Region) Analysis
Section 5 Global Preventable Vaccines Market Segmentation (by Product Type)
5.1 Product Introduction by Type
5.1.1 Adult Preventable Vaccines Product Introduction
5.1.2 Pediatric Preventable Vaccines Product Introduction
5.2 Global Preventable Vaccines Sales Volume by Pediatric Preventable Vaccines016-2021
5.3 Global Preventable Vaccines Market Size by Pediatric Preventable Vaccines016-2021
5.4 Different Preventable Vaccines Product Type Price 2016-2021
5.5 Global Preventable Vaccines Market Segmentation (By Type) Analysis
Section 6 Global Preventable Vaccines Market Segmentation (by Application)
6.1 Global Preventable Vaccines Sales Volume by Application 2016-2021
6.2 Global Preventable Vaccines Market Size by Application 2016-2021
6.2 Preventable Vaccines Price in Different Application Field 2016-2021
6.3 Global Preventable Vaccines Market Segmentation (By Application) Analysis
Section 7 Global Preventable Vaccines Market Segmentation (by Channel)
7.1 Global Preventable Vaccines Market Segmentation (By Channel) Sales Volume and Share 2016-2021
7.2 Global Preventable Vaccines Market Segmentation (By Channel) Analysis
Section 8 Preventable Vaccines Market Forecast 2021-2026
8.1 Preventable Vaccines Segmentation Market Forecast 2021-2026 (By Region)
8.2 Preventable Vaccines Segmentation Market Forecast 2021-2026 (By Type)
8.3 Preventable Vaccines Segmentation Market Forecast 2021-2026 (By Application)
8.4 Preventable Vaccines Segmentation Market Forecast 2021-2026 (By Channel)
8.5 Global Preventable Vaccines Price Forecast
Section 9 Preventable Vaccines Application and Client Analysis
9.1 Bacterial Diseases Customers
9.2 Virus Diseases Customers
Section 10 Preventable Vaccines Manufacturing Cost of Analysis
11.0 Raw Material Cost Analysis
11.0 Labor Cost Analysis
11.0 Cost Overview
Section 11 Conclusion
Section 12 Methodology and Data Source
Chart and Figure
Figure Preventable Vaccines Product Picture
Chart Global Preventable Vaccines Market Size (with or without the impact of COVID-19)
Chart Global Preventable Vaccines Sales Volume (Units) and Growth Rate 2016-2021
Chart Global Preventable Vaccines Market Size (Million $) and Growth Rate 2016-2021
Chart Global Preventable Vaccines Sales Volume (Units) and Growth Rate 2021-2026
Chart Global Preventable Vaccines Market Size (Million $) and Growth Rate 2021-2026
Chart 2016-2021 Global Manufacturer Preventable Vaccines Sales Volume (Units)
Chart 2016-2021 Global Manufacturer Preventable Vaccines Sales Volume Share
Chart 2016-2021 Global Manufacturer Preventable Vaccines Business Revenue (Million USD)
Chart 2016-2021 Global Manufacturer Preventable Vaccines Business Revenue Share
Chart GlaxoSmithKline Preventable Vaccines Sales Volume, Price, Revenue and Gross margin 2016-2021
Chart GlaxoSmithKline Preventable Vaccines Business Distribution
Chart GlaxoSmithKline Interview Record (Partly)
Chart GlaxoSmithKline Preventable Vaccines Business Profile
Table GlaxoSmithKline Preventable Vaccines Product Specification
Chart Merck Preventable Vaccines Sales Volume, Price, Revenue and Gross margin 2016-2021
Chart Merck Preventable Vaccines Business Distribution
Chart Merck Interview Record (Partly)
Chart Merck Preventable Vaccines Business Overview
Table Merck Preventable Vaccines Product Specification
…
…
Chart United States Preventable Vaccines Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart United States Preventable Vaccines Sales Price (USD/Unit) 2016-2021
Chart Canada Preventable Vaccines Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Canada Preventable Vaccines Sales Price (USD/Unit) 2016-2021
Chart Mexico Preventable Vaccines Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Mexico Preventable Vaccines Sales Price (USD/Unit) 2016-2021
Chart Brazil Preventable Vaccines Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Brazil Preventable Vaccines Sales Price (USD/Unit) 2016-2021
Chart Argentina Preventable Vaccines Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Argentina Preventable Vaccines Sales Price (USD/Unit) 2016-2021
Chart China Preventable Vaccines Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart China Preventable Vaccines Sales Price (USD/Unit) 2016-2021
Chart Japan Preventable Vaccines Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Japan Preventable Vaccines Sales Price (USD/Unit) 2016-2021
Chart India Preventable Vaccines Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart India Preventable Vaccines Sales Price (USD/Unit) 2016-2021
Chart Korea Preventable Vaccines Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Korea Preventable Vaccines Sales Price (USD/Unit) 2016-2021
Chart Southeast Asia Preventable Vaccines Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Southeast Asia Preventable Vaccines Sales Price (USD/Unit) 2016-2021
Chart Germany Preventable Vaccines Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Germany Preventable Vaccines Sales Price (USD/Unit) 2016-2021
Chart UK Preventable Vaccines Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart UK Preventable Vaccines Sales Price (USD/Unit) 2016-2021
Chart France Preventable Vaccines Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart France Preventable Vaccines Sales Price (USD/Unit) 2016-2021
Chart Spain Preventable Vaccines Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Spain Preventable Vaccines Sales Price (USD/Unit) 2016-2021
Chart Italy Preventable Vaccines Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Italy Preventable Vaccines Sales Price (USD/Unit) 2016-2021
Chart Africa Preventable Vaccines Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Africa Preventable Vaccines Sales Price (USD/Unit) 2016-2021
Chart Middle East Preventable Vaccines Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Middle East Preventable Vaccines Sales Price (USD/Unit) 2016-2021
Chart Global Preventable Vaccines Market Segmentation Sales Volume (Units) by Region 2016-2021
Chart Global Preventable Vaccines Market Segmentation Sales Volume (Units) Share by Region 2016-2021
Chart Global Preventable Vaccines Market Segmentation Market size (Million $) by Region 2016-2021
Chart Global Preventable Vaccines Market Segmentation Market size (Million $) Share by Region 2016-2021
Chart Adult Preventable Vaccines Product Figure
Chart Adult Preventable Vaccines Product Description
Chart Pediatric Preventable Vaccines Product Figure
Chart Pediatric Preventable Vaccines Product Description
Chart Preventable Vaccines Sales Volume (Units) by Pediatric Preventable Vaccines016-2021
Chart Preventable Vaccines Sales Volume (Units) Share by Type
Chart Preventable Vaccines Market Size (Million $) by Pediatric Preventable Vaccines016-2021
Chart Preventable Vaccines Market Size (Million $) Share by Pediatric Preventable Vaccines016-2021
Chart Different Preventable Vaccines Product Type Price ($/Unit) 2016-2021
Chart Preventable Vaccines Sales Volume (Units) by Application 2016-2021
Chart Preventable Vaccines Sales Volume (Units) Share by Application
Chart Preventable Vaccines Market Size (Million $) by Application 2016-2021
Chart Preventable Vaccines Market Size (Million $) Share by Application 2016-2021
Chart Preventable Vaccines Price in Different Application Field 2016-2021
Chart Global Preventable Vaccines Market Segmentation (By Channel) Sales Volume (Units) 2016-2021
Chart Global Preventable Vaccines Market Segmentation (By Channel) Share 2016-2021
Chart Preventable Vaccines Segmentation Market Sales Volume (Units) Forecast (by Region) 2021-2026
Chart Preventable Vaccines Segmentation Market Sales Volume Forecast (By Region) Share 2021-2026
Chart Preventable Vaccines Segmentation Market Size (Million USD) Forecast (By Region) 2021-2026
Chart Preventable Vaccines Segmentation Market Size Forecast (By Region) Share 2021-2026
Chart Preventable Vaccines Market Segmentation (By Type) Volume (Units) 2021-2026
Chart Preventable Vaccines Market Segmentation (By Type) Volume (Units) Share 2021-2026
Chart Preventable Vaccines Market Segmentation (By Type) Market Size (Million $) 2021-2026
Chart Preventable Vaccines Market Segmentation (By Type) Market Size (Million $) 2021-2026
Chart Preventable Vaccines Market Segmentation (By Application) Market Size (Volume) 2021-2026
Chart Preventable Vaccines Market Segmentation (By Application) Market Size (Volume) Share 2021-2026
Chart Preventable Vaccines Market Segmentation (By Application) Market Size (Value) 2021-2026
Chart Preventable Vaccines Market Segmentation (By Application) Market Size (Value) Share 2021-2026
Chart Global Preventable Vaccines Market Segmentation (By Channel) Sales Volume (Units) 2021-2026
Chart Global Preventable Vaccines Market Segmentation (By Channel) Share 2021-2026
Chart Global Preventable Vaccines Price Forecast 2021-2026
Chart Bacterial Diseases Customers
Chart Virus Diseases Customers
Research Methodology:
Preventable Vaccines Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|